Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
- Diagnostic Substances
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 26039
Dopascan Injection (â€œDopascanâ€) is a product candidate that is intended to measure dopamine transporter binding to diagnose and monitor the degree of Parkinsonâ€™s disease, a disease that affects more than one million patients in the United States. Dopascan is administered to patients intravenously and allows an attending physician to obtain images and measure the density of dopamine transporters in the patientâ€™s brain, which are highly concentrated in a specialized area of the brain and which are significantly decreased in patients with Parkinsonâ€™s disease.
IPSCIO Record ID: 26820
We are a development stage biotechnology company engaged in the research and development of biopharmaceutical products for the diagnosis and treatment of central nervous system diseases and for the treatment of some cancers and autoimmune diseases.
IPSCIO Record ID: 4453
In February 2004, the Licensor, further amended their contractual arrangements subject to the sale by a third party (original Licensee)of certain of its assets, including its rights to Zelapar and Permax, to the (current)Licensee. On 25 February 2004, third partyâ€™s sale of assets to Licensee closed and the amendments became effective.
IPSCIO Record ID: 27665
For Commercialization, Licensor grants an exclusive license, with the right to grant sublicenses, under Licensed Know-How and Licensed Patent Rights to make, have made, use, import, offer for sale and sell Licensed Products in the Field in the Territory.
The product name is ALTROPANE. Licensed Product means a pharmaceutical product, whether prescription or over-the-counter, for use in the Field containing [123I]-E-IACFT Injection.
Altropane is an iodine-123 radiolabeled imaging agent which is being developed as an aid in the diagnosis of Parkinsonâ€™s disease and movement disorders. Altropane and is a molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsonâ€™s Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB.